Manager, US Commercial and R&D
Latest From Reed Miller
Abbott expects the ongoing recovery of medical procedure volumes to continue even as new virus variants are causing COVID-19 cases to increase in some geographies.
Johnson & Johnson’s medical device sales were up nearly 60% year-over-year in the second quarter of 2021 while Abbott reported 51% growth in its device business, reflecting the recovery in procedure volumes since the worst days of the pandemic in mid-2020.
In this edition of Device Week, Medtech Insight’s Marion Webb reviews the huge number of digital health investments announced in 2021, including numerous SPAC deals. UK-based reporter Barnaby Pickering talks about Angle, a British liquid diagnostics company that has developed a novel approach to liquid diagnostics.
Pacific Biosciences has agreed to pay $600m upfront in cash and stock and up $200m in additional milestone payments to acquire Omniome. PacBio also announced a new private placement of common stock to raise $300m.
Digital Health Roundup, June 2021: Winners In Record-Breaking H1 Digital Health Funding; ADA 2021; Telehealth Update
In this roundup feature focusing on the developments in digital health, we highlight the key news and announcements from June.
Imperative Care Reacquires Truvic, Raises $260m To Advance Neurovascular And Peripheral Interventions
The proceeds from the series D financing will help Imperative Care advance its stroke-intervention technologies and Truvic’s peripheral intervention devices.